Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

Cancer and Alzheimer's are two of the most common chronic diseases associated with aging. For years, doctors have known about ...

ARIA is the most common side effect of anti–amyloid-beta MAB treatment. MABs increase vascular permeability, which can result in inflammation and leakage of proteinaceous fluid and blood products, ...

TORONTO -- An investigational antibody drug, designed to cross the blood-brain barrier (BBB) to eliminate amyloid-beta plaques associated with Alzheimer's disease, performed so well in a phase Ib/IIa ...

How can we influence whether we develop Alzheimer's disease later in life? Neurodegeneration researchers at the Institute for ...

While amyloid β plaques are hallmarks of Alzheimer’s disease (AD), recent research suggests that they aren’t the only players in the neurodegenerative disorder. Genome-wide association studies and RNA ...